Safety, Immunogenicity and Dose Ranging of a New Vi-CRM197 Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults

Title
Safety, Immunogenicity and Dose Ranging of a New Vi-CRM197 Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults
Authors
Keywords
Vaccines, Conjugate vaccines, Vaccination and immunization, Enzyme-linked immunoassays, Typhoid, Vaccine development, Fevers, Antigens
Journal
PLoS One
Volume 6, Issue 9, Pages e25398
Publisher
Public Library of Science (PLoS)
Online
2011-10-01
DOI
10.1371/journal.pone.0025398

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search